Chronic rapamycin treatment attenuates age-related motor deficits in sex-dependent manner in UM-HET3 mice
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 07.05.2026 · 81 (6)
DOI: 10.1093/gerona/glag070 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 21.03.2026. Verfasst von Rashmi Singh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States. Hauptthemen laut MEDLINE: Brain, Endoplasmic Reticulum Stress, Motor Activity, Protein Carbonylation. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIA NIH HHS, NIH HHS.
Abstract (Originalsprache)
Interventions Testing Program identified rapamycin as a robust lifespan-extending agent at multiple testing sites and in both sexes, with particularly strong effects in females, making it a leading candidate in aging research. We used genetically heterogeneous UM-HET3 mice of both sexes to determine whether rapamycin can prevent or delay age-sensitive traits. Mice were supplemented with microencapsulated rapamycin at 14 ppm starting at 12 months of age. Chronic rapamycin supplementation prevented the age-related decline in motor function, with females benefiting more than males. We further determined that rapamycin attenuated the age-related increase in protein carbonyls, principally in the insoluble protein fraction of brain regions that subserve motor function. We also found increased protein expression of glial fibrillary acidic protein (GFAP) across several brain regions, surprisingly, rapamycin treatment further increased GFAP levels in the striatum of both sexes, however this increase is not supporting evidence for a decrease in oxidative stress. Age-related increase in ER stress has been reported to be associated with increased protein carbonyls. We observed that rapamycin reduced the expression of C/EBP homologous protein (CHOP), a marker of ER stress-mediated apoptosis, in the striatum region of female mice. Our data show a novel beneficial effect of rapamycin on age-related motor deficits that is not sex-specific and that these changes are associated with reduction in protein carbonyls in brain regions linked to motor function. Furthermore, our results are consistent with the idea that rapamycin’s beneficial effects are mediated, at least in part, by reducing oxidative stress and ER stress-mediated apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
- Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
- Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
- Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
- Department of Biochemistry and Physiology, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma, United States.
- Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma, United States.
ORCID-Profile: Elizabeth Fernandez
Förderung
- BLRD VA
- NIA NIH HHS
- NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Singh, R., Calderon, V. E., Holstein, D., Diaz, V., Martinez, P. A., Galvan, V., Javors, M., Fernandez, E., Lechleiter, J., & Strong, R. (2026). Chronic rapamycin treatment attenuates age-related motor deficits in sex-dependent manner in UM-HET3 mice. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(6). https://doi.org/10.1093/gerona/glag070
Vancouver
Singh R, Calderon VE, Holstein D, Diaz V, Martinez PA, Galvan V, et al. Chronic rapamycin treatment attenuates age-related motor deficits in sex-dependent manner in UM-HET3 mice. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(6). doi:10.1093/gerona/glag070
BibTeX
@article{Singh2026,
author = {Singh, Rashmi and Calderon, Vanessa Elia and Holstein, Deborah and Diaz, Vivian and Martinez, Paul Anthony and Galvan, Veronica and Javors, Martin and Fernandez, Elizabeth and Lechleiter, James and Strong, Randy},
title = {Chronic rapamycin treatment attenuates age-related motor deficits in sex-dependent manner in UM-HET3 mice},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {6},
doi = {10.1093/gerona/glag070}
}
EUVIMED